Evolutionary druggability for low-dimensional fitness landscapes toward new metrics for antimicrobial applications.

Abstract excerpt

The term 'druggability' describes the molecular properties of drugs or targets in pharmacological interventions and is commonly used in work involving drug development for clinical applications. There are no current analogues for this notion that quantify the drug-target interaction with respect to a given target variant's sensitivity across a breadth of drugs in a panel, or a given drug's range of effectiveness...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Alleles
• Share to Anti-Bacterial Agents